ARS Pharmaceuticals, Inc.

UBS Group AG SPRY
Report date
3/31/2026
Quarter
2026 Q1
Filed
5/5/2026
Shares
2,260,325
Value ($000)
18,150
Weight
0.0%
2020 Q4 - 2026 Q1 (19 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).